Kymera Therapeutics Inc (KYMR) Insider Trading

Total insider buys:
  • $64,580,508.56
Total insider sells:
  • $110,920,741.05
Most recent insider trade:
  • March 15, 2024
Most active insider trader:
  • Nello Mainolfi
Trader NameDateTitleAmountPriceTypeTotal Value
March 15, 2024Director71,764$40.46Sell$2,903,571.44
March 13, 2024Major Shareholder115,090$42.23Sell$4,860,250.70
March 13, 2024Director139,255$42.23Sell$5,880,738.65
March 11, 2024Major Shareholder42,302$42.85Sell$1,812,640.70
March 11, 2024Director51,184$42.85Sell$2,193,234.40
March 4, 2024CFO3,934$41.86Sell$164,677.24
Feb. 21, 2024Director4,385$39.05Sell$171,234.25
Feb. 9, 2024Insider46,137$35.50Sell$1,637,863.50
Jan. 23, 2024Director10,000$30.05Sell$300,500.00
Jan. 4, 2024Insider3,295$22.58Sell$74,401.10
Nov. 2, 2023Director216,406$11.64Buy$2,518,965.84
March 2, 2023CFO1,370$31.00Sell$42,470.00
Jan. 11, 2023Director22,110$29.89Buy$660,867.90
Jan. 11, 2023Major Shareholder21,683$29.96Sell$649,622.68
Dec. 14, 2022Major Shareholder296,077$31.37Sell$9,287,935.49
Dec. 14, 2022Director378,966$31.37Sell$11,888,163.42
Nov. 2, 2022Major Shareholder96,581$30.02Sell$2,899,361.62
Nov. 2, 2022Director123,619$30.02Sell$3,711,042.38
Oct. 31, 2022Major Shareholder94,239$30.23Sell$2,848,844.97
Oct. 31, 2022Director120,622$30.23Sell$3,646,403.06
Oct. 28, 2022Major Shareholder71,135$30.00Sell$2,134,050.00
Oct. 28, 2022Director91,050$30.00Sell$2,731,500.00
Aug. 22, 2022Director545,525$26.00Buy$14,183,650.00
May 26, 2022Director224,057$14.21Buy$3,183,849.97
May 20, 2022Director10,100$14.00Buy$141,400.00
May 5, 2022Director150,000$19.60Buy$2,940,000.00
Jan. 31, 2022Director34,408$40.70Buy$1,400,405.60
Jan. 27, 2022Director95,901$38.33Buy$3,675,885.33
Jan. 24, 2022Director272,767$37.76Buy$10,299,681.92
Jan. 12, 2022CEO8,612$52.08Sell$448,512.96
Jan. 12, 2022CFO15,000$51.85Sell$777,750.00
Jan. 10, 2022CEO22,465$53.26Sell$1,196,485.90
Dec. 3, 2021CFO10,000$53.56Sell$535,600.00
Nov. 2, 2021Insider14,996$63.22Sell$948,047.12
Oct. 11, 2021CEO6,456$53.68Sell$346,558.08
Oct. 8, 2021CEO41,544$56.76Sell$2,358,037.44
Sept. 3, 2021CFO10,000$60.12Sell$601,200.00
Aug. 27, 2021Insider33,779$60.12Sell$2,030,793.48
Aug. 17, 2021Insider54,000$50.37Sell$2,719,980.00
Aug. 11, 2021Director242,133$61.00Sell$14,770,113.00
Aug. 4, 2021CEO1,037$60.03Sell$62,251.11
Aug. 2, 2021CEO23,456$60.30Sell$1,414,396.80
July 30, 2021CEO6,279$60.07Sell$377,179.53
July 28, 2021CEO3,864$60.15Sell$232,419.60
July 26, 2021CEO9,015$60.15Sell$542,252.25
July 8, 2021CEO48,000$49.70Sell$2,385,600.00
July 1, 2021Director544,166$47.00Buy$25,575,802.00
June 9, 2021CEO5,752$50.02Sell$287,715.04
June 7, 2021CEO12,724$50.14Sell$637,981.36
June 3, 2021CFO10,000$46.87Sell$468,700.00
First«1 of 2»Last
  • Insiders are both buying and selling Kymera Therapeutics Inc stock.

  • The insider traders at Kymera Therapeutics Inc are: Nello Mainolfi, Bvf Partners L P/Il, Bruce Booth, Bruce N Jacobs, Venture Fund X L.P. Atlas, Jared Gollob, Jeffrey W. Albers, Richard Chesworth, Ellen Chiniara, and Bruce N. Jacobs

  • The most active insider trader at Kymera Therapeutics Inc is Nello Mainolfi with 19 trades.

  • Bruce Booth has sold the most Kymera Therapeutics Inc stock with a total value of $63,586,612.79.

  • Bvf Partners L P/Il has bought the most Kymera Therapeutics Inc stock with a total value of $67,099,474.40.

  • The most recent insider trade for Kymera Therapeutics Inc was on March 15, 2024.

  • The single biggest insider buy for Kymera Therapeutics Inc was from Bvf Partners L P/Il with a total value of $25,575,802.00 on July 1, 2021.

  • The single biggest insider sell for Kymera Therapeutics Inc was from Bruce Booth with a total value of $14,770,113.00 on Aug. 11, 2021.